96

Contamination Control Compass
Edition #04/2024

Informative Articles
Introduction to the world of digital PCR

Discover a groundbreaking advance in molecular detection with the latest article on digital polymerase chain reaction (dPCR). Get a clear understanding of the basics of conventional PCR and see how dPCR builds on this fundamental technology. Learn why this innovative method is called ‘digital’ and how it differs from conventional PCR.
Don't miss this informative article that could change the way you approach genetic research and biopharmaceutical testing. The applications of dPCR are far-reaching.

We are exhibiting at ISCT 2024 Vancouver May 29 - June 1.

We will be presenting our latest product developments for determination of vector copy number in CAR-T cell therapy, determination of adeno-associated virus vector titer in cell therapy and complete pyrogen testing based on digital PCR.
You'll find us at booth #534. We look forward to seeing you there!

Product Highlights
Residual Host Cell DNA Testing by digital PCR

Residual host cell DNA testing is a critical quality control aspect in the production of biopharmaceuticals, including recombinant proteins, monoclonal antibodies, and cell-based therapies.
MiQuant® Residual DNA dPCR kits are ready-to-use TaqMan based dPCR assays and have been developed for the detection of residual host cell DNA for E.coli, CHO or HEK-293 cells. All reagents including the polymerase are freeze-dried and only need to be resuspended in rehydration buffer.


Why to choose MiQuant® Residual DNA dPCR kits?

✓ Fast workflow as no sample preparation is required

✓ Meets EP, WHO and FDA criteria

✓ Compatible with QIAcuity® dPCR platform

✓ Novel rapid, robust and sensitive method

✓ Lyophilized kit components simplify logistics and storage

Here's to clean cultures and reliable results!


Warm regards,

Your MB Team

Do you need technical support or have questions regarding our products? Please contact support@minerva-biolabs.com. Any feedback or suggestions? Write an email to newsletter@minerva-biolabs.com.